Research at the College of Medicine
Medical faculty are among the scientists conducting breakthrough research at the Evelyn F. and William L. McKnight Brain Institute of UF, the UF Institute on Aging and the UF Genetics Institute. The UF Shands Cancer Center is establishing itself as a leading cancer program, coordinating multidisciplinary approaches to the development of treatment strategies directed toward providing quality patient care.
College of Medicine faculty have attained national leadership in patient care, research and education related to the brain and spine, cancer, diabetes, drug design, genetics and organ transplantation. With contributions from the College of Medicine faculty in the development of new health-related technologies and products, UF ranks among the top 10 U.S. universities in licensing income and averages more than 50 issued patents each year. Two of the most widely recognized products to come out of research at the College of Medicine are Gatorade, a popular sports beverage, and Trusopt, an eye drop developed to treat certain forms of glaucoma.
The College of Medicine's research-based funding for fiscal year 2009-2010 reached a high of $335 million. The college's total support for research accounted for more than 49 percent of the $678 million UF received in funding. Research funding in the College of Medicine has more than doubled in the last decade. With contributions from the College of Medicine faculty in the development of new health-related technologies and products, UF annually applies for approximately 150 patents and licenses 70 technologies. The Milken Institute has ranked UF as the top-performing public institution at transferring its research to the marketplace.
